Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis

被引:119
|
作者
Dokras, Anuja [1 ]
Clifton, Shari [2 ]
Futterweit, Walter [3 ]
Wild, Robert [2 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Mt Sinai Sch Med, New York, NY USA
关键词
PCOS; anxiety disorder; meta-analysis; QUALITY-OF-LIFE; INCREASED RISK; MENTAL-HEALTH; DEPRESSION; DISORDERS; COMORBIDITY;
D O I
10.1016/j.fertnstert.2011.10.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To perform a systematic review and meta-analysis of studies that compared the prevalence of anxiety symptoms in women with polycystic ovary syndrome (PCOS) and control women. Design: Meta-analysis and systematic review. Setting: University practice. Patient(s): Cross-sectional studies comparing PCOS subjects and geographically matched clearly defined non-PCOS control subjects with data on age and body mass index (BMI). Intervention(s): Anxiety screening tool. Main Outcome Measure(s): The primary analysis contrasted prevalence of anxiety. Cochrane Review Manager 5.0.24 software was used to construct forest plots comparing frequency of anxiety symptoms in case and control subjects. Result(s): Of 613 screened articles, nine met our selection criteria for a systematic review and four were included in the meta-analysis. The prevalence of generalized anxiety symptoms was available in four studies and was significantly greater in PCOS subjects (42/206, 20.4%) compared to controls (8/204, 3.9%). The odds for anxiety symptoms were significantly greater in women with PCOS compared with control subjects (odds ratio 6.88, 95% confidence interval 2.5-18.9). The mean anxiety score was significantly increased in three of the remaining five studies. Other anxiety disorders, such as social phobia, panic attacks, and obsessive compulsive disorders, were assessed infrequently. Conclusion(s): Our systematic review suggests an increased odds of anxiety symptoms in women with PCOS, underscoring the importance of screening all women with PCOS for anxiety symptoms. Follow-up evaluation and treatment are essential, because generalized anxiety disorder is a chronic condition. Potential contributors for anxiety symptoms, such as hirsutism, obesity, and/or infertility may be specific to women with PCOS but need further investigation. (Fertil Steril (R) 2012;97:225-30. (C) 2012 by American Society for Reproductive Medicine.)
引用
收藏
页码:225 / U381
页数:8
相关论文
共 50 条
  • [1] High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
    Cooney, Laura G.
    Lee, Iris
    Sammel, Mary D.
    Dokras, Anuja
    [J]. HUMAN REPRODUCTION, 2017, 32 (05) : 1075 - 1091
  • [2] Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis
    Barry, J. A.
    Kuczmierczyk, A. R.
    Hardiman, P. J.
    [J]. HUMAN REPRODUCTION, 2011, 26 (09) : 2442 - 2451
  • [3] The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis
    Naz, Marzieh Saei Ghare
    Tehrani, Fahimeh Ramezani
    Majd, Hamid Alavi
    Ahmadi, Fazlollah
    Ozgoli, Giti
    Fakari, Farzaneh Rashidi
    Ghasemi, Vida
    [J]. INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2019, 17 (08) : 533 - 542
  • [4] Increased Prevalence of Binge Eating Disorder and Bulimia Nervosa in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
    Cooney, Laura G.
    Gyorfi, Kaley
    Sanneh, Awa
    Bui, Leeann M.
    Mousa, Aya
    Tay, Chau Thien
    Teede, Helena
    Stener-Victorin, Elisabet
    Brennan, Leah
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [5] Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis
    Niksima, Seyed Hassan
    Odel, Naji M.
    Khaki, Soore
    Gheshlagh, Reza Ghanei
    Fallahi, Arezoo
    Kurdi, Amanj
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 1911 - 1915
  • [6] Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis
    Salari, Nader
    Nankali, Anisodowleh
    Ghanbari, Amirhossaien
    Jafarpour, Sima
    Ghasemi, Hooman
    Dokaneheifard, Sadat
    Mohammadi, Masoud
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (03) : 1303 - 1314
  • [7] The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis
    Kahal, Hassan
    Kyrou, Ioannis
    Uthman, Olalekan A.
    Brown, Anna
    Johnson, Samantha
    Wall, Peter D. H.
    Metcalfe, Andrew
    Parr, David G.
    Tahrani, Abd A.
    Randeva, Harpal S.
    [J]. SLEEP AND BREATHING, 2020, 24 (01) : 339 - 350
  • [8] The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis
    Hassan Kahal
    Ioannis Kyrou
    Olalekan A. Uthman
    Anna Brown
    Samantha Johnson
    Peter D. H. Wall
    Andrew Metcalfe
    David G. Parr
    Abd A. Tahrani
    Harpal S. Randeva
    [J]. Sleep and Breathing, 2020, 24 : 339 - 350
  • [9] The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis
    Khorshidi, Ali
    Azami, Milad
    Tardeh, Samira
    Tardeh, Zeinab
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2747 - 2753
  • [10] The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis
    Wang, Yulu
    Ni, Zhihong
    Li, Keyi
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (12) : 1072 - 1078